The pancreatic and biliary stent market size was $750.5 million in 2021. Â The pancreatic and biliary stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts. Increase in the number of ERCP and PTC procedures has fueled the market especially the procedures requiring stenting and recurrent stenting.
The pancreatic and biliary stent market report is built to visualize quantitative market trends within general surgery devices therapeutic area. The model discusses in detail the impact of COVID-19 on pancreatic and biliary stents market for the year 2020 and beyond. Pancreatic and biliary stents are the tubular devices made either of plastic or metal. They are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These stents are also for preventing post- endoscopic retrograde cholangiopancreatography pancreatitis and to drain the gallbladder and pancreatic fluids. These stents are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).
Pancreatic and biliary stent market outlook
For more insights on this report, download a free sample
Which are the key regions in the pancreatic and biliary stents market?
The key regions in the pancreatic and biliary stents market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.
Pancreatic and biliary stents market, by key regions
For more region insights, download a free sample
Which are the key countries in the pancreatic and biliary stents market?
There are 39 key countries in the pancreatic and biliary stents market, these include Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US.
Pancreatic and biliary stents market, by key countries
For more country insights, download a free sample
What are the key segments in the pancreatic and biliary stents market?
The key segments in the pancreatic and biliary stents market are metal stents and plastic stents.
Pancreatic and biliary stents market, by segments
For more segment insights, download a free sample
Which are the key companies in the pancreatic and biliary stents market?
The key companies in the pancreatic and biliary stents market are Boston Scientific Corp, Becton Dickinson and Co, Hellman & Friedman LLC, ConMed Corp, Cook Group Inc, Hobbs Medical Inc, Medtronic Plc, Olympus Corp, and W. L. Gore & Associates Inc.
Pancreatic and biliary stents market, by key companies
To know more about key companies, download a free sample
Market report overview
Market size 2021 | $750.5 million |
Market size 2021 Key regions | North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa |
Key countries | Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US |
Key segments | Metal Stents and Plastic Stents |
Key companies | Boston Scientific Corp, Becton Dickinson and Co, Hellman & Friedman LLC, ConMed Corp, Cook Group Inc, Hobbs Medical Inc, Medtronic Plc, Olympus Corp, and W. L. Gore & Associates Inc |
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
- CMO executives who must have deep understanding of the Pancreatic and Biliary Stents marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to:
- Understand the impact of COVID-19 on Pancreatic and Biliary Stents market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Pancreatic and Biliary Stents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Pancreatic and Biliary Stents market in the future.
Key Players
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
The pancreatic and biliary stents market size was $750.5 million in the year 2021.
North America, South & Central America, Europe, Asia-Pacific, and Middle East & Africa are the key regions in the pancreatic and biliary stents market.
Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US are the key countries in the pancreatic and biliary stents market.
Metal stents and plastic stents are the key segments in the pancreatic and biliary stents market.
Boston Scientific Corp, Becton Dickinson and Co, Hellman & Friedman LLC, ConMed Corp, Cook Group Inc, Hobbs Medical Inc, Medtronic Plc, Olympus Corp, and W. L. Gore & Associates Inc are the key companies in the pancreatic and biliary stents market.